Anti-human CCL24 monoclonal antibody (CM-101) clinical trials

CM-101 in PSC Patients -The SPRING Study

This study, called The SPRING Study, is looking into a new medication called CM-101 for adults with a liver condition called Primary Sclerosing Cholangitis (PSC). It aims to see if CM-101 is safe, well-tolerated, and helpful in treating PSC.